MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on July 23, 2007; DOI: 10.1124/mol.107.037127


0026-895X/07/7205-1228-1237$20.00
Mol Pharmacol 72:1228-1237, 2007

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.107.037127v1
72/5/1228    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Related articles in MolPharm
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fontana, A. C. K.
Right arrow Articles by Amara, S. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fontana, A. C. K.
Right arrow Articles by Amara, S. G.

Enhancing Glutamate Transport: Mechanism of Action of Parawixin1, a Neuroprotective Compound from Parawixia bistriata Spider Venom

Andréia Cristina Karklin Fontana, Renê de Oliveira Beleboni, Marcin Wlodzimierz Wojewodzic, Wagner Ferreira dos Santos, Joaquim Coutinho-Netto, Nina Julie Grutle, Spencer D. Watts, Niels Christian Danbolt, and Susan G. Amara

Department of Neurobiology, University of Pittsburgh, Pittsburgh, Pennsylvania (A.C.K.F., S.D.W., S.G.A.); Laboratory of Neurochemistry, Department of Biochemistry and Immunology, Ribeirão Preto School of Medicine, University of São Paulo, São Paulo, Brazil (R.d.O.B., J.C.-N.); Laboratory of Neurobiology and Venoms, Department of Biology, Ribeirão Preto Faculty of Philosophy, Sciences and Literature, University of São Paulo, São Paulo, Brazil (W.F.d.S.); and Centre of Molecular Biology and Neuroscience and Department of Anatomy, Institute of Basic Medical Sciences, University of Oslo, Blindern, Norway (M.W.W., N.J.G., N.C.D.)

Previous studies have shown that a compound purified from the spider Parawixia bistriata venom stimulates the activity of glial glutamate transporters and can protect retinal tissue from ischemic damage. To understand the mechanism by which this compound enhances transport, we examined its effects on the functional properties of glutamate transporters after solubilization and reconstitution in liposomes and in transfected COS-7 cells. Here, we demonstrate in both systems that Parawixin1 promotes a direct and selective enhancement of glutamate influx by the EAAT2 transporter subtype through a mechanism that does not alter the apparent affinities for the cosubstrates glutamate or sodium. In liposomes, we observed maximal enhancement by Parawixin1 when extracellular sodium and intracellular potassium concentrations are within physiological ranges. Moreover, the compound does not enhance the reverse transport of glutamate under ionic conditions that favor efflux, when extracellular potassium is elevated and the sodium gradient is reduced, nor does it alter the exchange of glutamate in the absence of internal potassium. These observations suggest that Parawixin1 facilitates the reorientation of the potassium-bound transporter, the rate-limiting step in the transport cycle, a conclusion further supported by experiments showing that Parawixin1 does not stimulate uptake by an EAAT2 transport mutant (E405D) defective in the potassium-dependent reorientation step. Thus, Parawixin1 enhances transport through a novel mechanism targeting a step in the transport cycle distinct from substrate influx or efflux and provides a basis for the design of new drugs that act allosterically on transporters to increase glutamate clearance.


Received April 19, 2007; accepted July 23, 2007

Address correspondence to: Andréia C. K. Fontana, University of Pittsburgh, Department of Neurobiology, 6068 BST3, 3501 Fifth Ave., Pittsburgh, PA 15260. E-mail: fontanaa{at}pitt.edu


Related articles in MolPharm:

Parawixin1: A Spider Toxin Opening New Avenues for Glutamate Transporter Pharmacology
Delany Torres-Salazar and Christoph Fahlke
MolPharm 2007 72: 1100-1102. [Abstract] [Full Text]  



This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
D. Torres-Salazar and C. Fahlke
Parawixin1: A Spider Toxin Opening New Avenues for Glutamate Transporter Pharmacology
Mol. Pharmacol., November 1, 2007; 72(5): 1100 - 1102.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics